[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343259-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343259-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","simultaneous-detection-of-collagen-i-alpha-ii-and-cytokeratin-19-mrna-by-multiplex-qpcr-in-liquid-biopsy-in-diagnosis-of-patients-with-resectable-solid-tumors","Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors","","Early tumor detection is a key factor for improving overall survival, yet many cancers lack reliable non-invasive screening methods. This work aimed to develop an RT-qPCR-based plasma screening approach for multiple carcinomas using a two-marker panel targeting stromal and epithelial biomarkers. A retrospective case-control study measured COL1A2 and KRT19 mRNA in plasma from 47 non-metastatic tumor cases and 13 controls via multiplex quantitative PCR. ROC analysis defined cut-offs using Youden’s J and quantified diagnostic performance. Combined biomarker analysis yielded AUC 0.897 with sensitivity 83% and specificity 84.6%, supporting early-stage multi-cancer detection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/simultaneous-detection-of-collagen-i-alpha-ii-and-cytokeratin-19-mrna-by-multiplex-qpcr-in-liquid-biopsy-in-diagnosis-of-patients-with-resectable-solid-tumors/343259/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/simultaneous-detection-of-collagen-i-alpha-ii-and-cytokeratin-19-mrna-by-multiplex-qpcr-in-liquid-biopsy-in-diagnosis-of-patients-with-resectable-solid-tumors/343259.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To develop a non-invasive screening method for early detection of various carcinomas in plasma using RT-qPCR with a two-marker panel.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biomarkers were evaluated in plasma?",{"text":68,"@type":64},"COL1A2 (stromal) and KRT19 (epithelial) mRNA were measured in plasma samples.",{"name":70,"@type":61,"acceptedAnswer":71},"How was diagnostic performance assessed?",{"text":72,"@type":64},"Biomarker expression was analyzed with multiplex quantitative PCR, and cut-off values were established using Youden’s J index and ROC curve analysis with AUC calculation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343259,1790444576,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nSimultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors  \nLara Sofía Estévez Pérez 1, *,†, Begoña O. Alén 1, *,†, María Otero Alén 2, Saioa Domínguez Hormaetxe 3, Laureano Simón 3 and Ángel Concha 1  \nCitation: Estévez Pérez, L.S.; Alén, B.O.; Otero Alén, M.; Hormaetxe, S.D.; Simón, L.; Concha, Á . Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors. Int. J. Mol. Sci. 2024, 25, 9567. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25179567](doi.org/10.3390/ijms25179567)  \nAcademic Editor: Bruna Scaggiante  \nReceived: 12 July 2024  \nRevised: 27 August 2024  \nAccepted: 29 August 2024  \nPublished: 3 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Pathology Department, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain; [angel.concha.lopez@sergas.es](angel.concha.lopez@sergas.es)  \n2 Santiago de Compostela Health Research Institute (IDIS), University Hospital Complex Santiago de Compostela, 15706 Santiago de Compostela, Spain; [maria.otero.alen@sergas.es](maria.otero.alen@sergas.es)  \n[3](3 Oncomatryx Biopharma)[ Oncomatryx Biopharma](3 Oncomatryx Biopharma), [48160 Derio](48160 Derio), [Spain](Spain); [sdominguez@oncomatryx.com](sdominguez@oncomatryx.com) ([S.D.H](S.D.H).);  \nlsimon@oncomatryx.com (L.S.)  \n* Correspondence: [lara.estevez.perez@gmail.com](lara.estevez.perez@gmail.com) (L.S.E.P.); [begona.otero.alen@sergas.es](begona.otero.alen@sergas.es) (B.O.A.);  \nTel.: +34-981178000 (L.S.E.P. & B.O.A.)† These authors contributed equally to this work.  \nAbstract: The early detection of tumors is one of the key factors in increasing overall survival in cancer patients. A wide range of cancers still do not have a system of early diagnosis; therefore, the development of new non-invasive tools in this line is essential. Accordingly, the objective of our work was to develop a non-invasive screening method for the early detection of various carcinomasin plasma using a panel that combines two markers using RT-qPCR. A retrospective case-control study was conducted to develop a cancer screening test based on the detection of stromal and epithelial biomarkers (COL1A2 and KRT19) in plasma. The expression of biomarkers was evaluated using multiplex quantitative PCR applied to 47 cases with non-metastatic tumors and 13 control participants. For both biomarkers, a cut-off value was stablished using Youden’s J index through ROC curve analysis and areas under the curve (AUC) were calculated. The plasma mRNA expression level of both biomarkers was significantly higher in diseased versus healthy patients. Moreover, ROC curve analysis showed an AUC value of 0.897 for the combined model. This model also resulted in a cutoff value of 0.664, as well as a sensitivity of 83% and a specificity of 84.6% . These results suggest that the plasma expression levels of COL1A2 and KRT19 could a have potential role in detecting various types of cancer at the early stages. The combined analysis of both stromal and epithelial biomarkers would provide a non-invasive screening method that would allow us to differentiate patients with an active neoplastic process.  \nKeywords: COL1A2; KRT19; early detection multi-cancer screening; multiplex RT-qPCR; liquid biopsy  \n1. Introduction  \nDespite the advances in surgical techniques and targeted treatments in recent years, cancer remains one of the leading causes of death in the world [1] . Early detection isone of the ke","cbCaipgMYp6lUaWh","https://ap.wps.com/l/cbCaipgMYp6lUaWh","pdf",4201224,15,"English","# Abstract\n# Introduction\n## Early detection and survival impact\n## Biomarker discovery and validation\n## Role of liquid biopsy and multiplex tests","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To develop a non-invasive screening method for early detection of various carcinomas in plasma using RT-qPCR with a two-marker panel.\"},{\"question\":\"Which biomarkers were evaluated in plasma?\",\"answer\":\"COL1A2 (stromal) and KRT19 (epithelial) mRNA were measured in plasma samples.\"},{\"question\":\"How was diagnostic performance assessed?\",\"answer\":\"Biomarker expression was analyzed with multiplex quantitative PCR, and cut-off values were established using Youden’s J index and ROC curve analysis with AUC calculation.\"}]","Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors | PDF",1790050476,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba4503a9f96b4d66396d13d0599d7c02.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c184c196ee0ef947034e1cc7e0de102.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20de1155d0d1269758d464c51be4936c.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36c39b54e681eb93232e5772f688a0ba.webp",980,1385]